SKIP TO
CONTENT
Philips Recalled CPAP, Bi-Level PAP, and Mechanical...
featured news
April 14, 2014
Healthcare Fraud
Duke University Health System to Pay $1 Million to Settle False Claims Act Allegations
The world-renowned Duke University School of Medicine operates out of three area hospitals owned by the Duke University Health System. According to a recently-unsealed False Claims Act filing in the federal District Court of the Eastern District of North Carolina, several of its billing practices allegedly violated the FCA and […]
April 10, 2014
Healthcare Fraud
Repeat Offender Valley Heart Consultants to Pay $3.9 Million to Settle Claims of Medicare Fraud
In a recent press release, the Department of Justice applauds the concerted efforts of the Department of Health and Human Services with the FBI in identifying and investigating allegations of billing fraud spanning nearly six years. According to allegations, Texas-based Valley Heart Consultants was engaging in the practice of performing […]
April 9, 2014
Healthcare Fraud
Arkansas Supreme Court Takes Different View of Risperdal Fraud Case
Late last year, the federal Department of Justice settled a long-running dispute with drug maker Johnson & Johnson over allegations of the off-label marketing of the anti-psychotic drug Risperdal. As is often the case, Johnson & Johnson also faced several state False Claims Act and Deceptive Trade Practices Act allegations, […]
April 7, 2014
Healthcare Fraud
Ohio-Area Memorial Hospital to Pay $8.5 Million for False Claims Act Violations
Memorial Hospital, located in Fremont, Ohio, is a non-profit organization allegedly involved in improper billing practices for services provided to Medicare and Medicaid patients. It has also recently resolved allegations under the Stark Law involving unlawful financial relationships with other entities in the medical field. All in all, Memorial has […]
April 4, 2014
Healthcare Fraud
Medicare Fraud Case Takes Aim at Unnecessary Prescriptions of Dangerous Drug Clozapine
In a case involving Teva Pharmaceuticals USA, LLC, the Department of Justice recently settled hundreds of allegations of Medicare and Medicaid fraud relating to the improper recommendation of the generic drug clozapine – considered a drug of last resort for the treatment of schizophrenia. According to allegations, Teva, through its […]
schedule a free consultation
"*" indicates required fields
By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.
$50B+
in Settlements & Verdicts
50+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated
On the Cutting Edge of the Profession
Legal Intelligencer
53
Years
